Publicaciones en colaboración con investigadores/as de University of Milan (30)

2023

  1. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    The Lancet Respiratory Medicine, Vol. 11, Núm. 7, pp. 637-649

  2. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting Best Practice

    American Journal of Respiratory and Critical Care Medicine, Vol. 207, Núm. 9, pp. 1134-1144

  3. Erratum: Hemorrhage, disseminated intravascular coagulopathy, and thrombosis complications among critically ill patients with COVID-19: An International COVID-19 Critical Care Consortium Study (Critical Care Medicine (2023) 51 (619-631) DOI: 10.1097/CCM.0000000000005798)

    Critical Care Medicine

  4. Hemorrhage, Disseminated Intravascular Coagulopathy, and Thrombosis Complications among Critically Ill Patients with COVID-19: An International COVID-19 Critical Care Consortium Study∗

    Critical Care Medicine, Vol. 51, Núm. 5, pp. 619-631

  5. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data

    International Journal of Obesity, Vol. 46, Núm. 4, pp. 750-757

  2. Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis

    Critical Care, Vol. 26, Núm. 1

2021

  1. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

    Critical Care, Vol. 25, Núm. 1

  2. An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: The rome proposal

    American Journal of Respiratory and Critical Care Medicine, Vol. 204, Núm. 11, pp. 1251-1258

  3. Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients with Coronavirus Disease 2019: An International Cohort Study

    Critical Care Explorations, Vol. 3, Núm. 11, pp. E0567

  4. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

    European Journal of Clinical Microbiology and Infectious Diseases

  5. Design and Rationale of a Prospective International Follow-Up Study on Intensive Care Survivors of COVID-19: The Long-Term Impact in Intensive Care Survivors of Coronavirus Disease-19–AFTERCOR

    Frontiers in Medicine, Vol. 8

  6. Development and characterization of a new swine model of invasive pneumococcal pneumonia

    Lab Animal, Vol. 50, Núm. 11, pp. 327-335

  7. Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant staphylococcus aureus pneumonia

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  8. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  9. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  10. Short-term effects of appropriate empirical antimicrobial treatment with ceftolozane/tazobactam in a swine model of nosocomial pneumonia

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 2

  11. Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis

    Annals of the American Thoracic Society, Vol. 18, Núm. 8, pp. 1316

2020

  1. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

    Frontiers in Medicine, Vol. 7

  2. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel

    Chest, Vol. 158, Núm. 5, pp. 1912-1918